PharmaVOICE Blog Post

Announcing the Spring Issue of THE EVIDENCE FORUM: A Focus on Digital Technologies

Posted By: Dan Limbach
May 11, 2020

Access the issue now

Evidera’s biannual publication focused on the scientific, strategic, and operational challenges of today’s healthcare environment.

This issue highlights a variety of topics to address our industry’s most pressing issues, such as working in the era of COVID-19, continuing to engage patients and their preferences in drug development, and understanding the latest insights and guidance from industry stakeholders.

Articles include:

  • Digital Approaches in the Era of COVID-19: Interviews with Science 37 and Medable
  • Decentralized RWE Data Collection Strategies during the COVID-19 Pandemic and Beyond
  • A Systematic Approach to Assessing Real-World Research Questions Supported by Digital Enablement
  • Leveraging Simulation to Patch a Clinical Trial Broken by COVID-19
  • Evidence Generation Using Innovative, Technology-Driven Data Collection
  • Surprises You Don’t Want When Adopting eCOAs for Use in Clinical Trials: Cautions for Decision Making and Planning
  • Digital Therapeutics: Past Trends and Future Prospects
  • US FDA’s Emergency Use Authorization (EUA): Applicability for Marketed and/or Investigational Products for Treatment of COVID-19
  • Integrated Scientific Advice during the COVID-19 Pandemic
  • Trends in Medical Device Purchasing, Evaluation of Value, and Advice for Manufacturers: An Interview with Vizient
  • Patient Preference Studies in HTA Decision Making: A NICE to Have?
  • Version 4.1 of the AMCP Format: Introducing a Trio of Dossiers to Support a Product Throughout its Lifecycle

Access the issue now


About the Blog Poster: Dan Limbach

Comments are closed.